Ridaforolimus as a single agent in advanced endometrial cancer: Results of a single-arm, phase 2 trial
N. Colombo*, D. S. McMeekin, P. E. Schwartz, C. Sessa, P. A. Gehrig, R. Holloway, P. Braly, D. Matei, A. Morosky, P. F. Dodion, M. H. Einstein, F. Haluska
Dive into the research topics of 'Ridaforolimus as a single agent in advanced endometrial cancer: Results of a single-arm, phase 2 trial'. Together they form a unique fingerprint.